PDPK1 anticorps (AA 506-556)
Aperçu rapide pour PDPK1 anticorps (AA 506-556) (ABIN7452710)
Antigène
Voir toutes PDPK1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 506-556
-
Fonction
- Rabbit anti-PDK1 Antibody, Affinity Purified
-
Purification
- Affinity Purified
-
Immunogène
- between AA 506 and 556
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IP: 5 - 10 μg/mg lysate
WB: 1:2,000 - 1:10,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Date de péremption
- 12 months
-
-
- PDPK1 (3-phosphoinositide Dependent Protein Kinase-1 (PDPK1))
-
Autre désignation
- PDK1
-
Sujet
- Background: PDK1 (3-phosphoinositide-dependent kinase-1) is a serine/threonine kinase that contains a PH domain for binding of phosphatidylinositols (PtdIns). PDK1 phosphorylates PKB/AKT in response to agonist stimulation of phosphoinositide 3-kinases (PI3Ks). Stimulation of PI3Ks generates specific inositol lipids that are important for activation of PDK1. PDK1 may also be responsible for phosphorylating PKA, PKC-zeta, RPS6KA1, and RPS6KB1.
-
ID gène
- 5170
-
NCBI Accession
- NP_002604
-
UniProt
- O15530
-
Pathways
- Signalisation PI3K-Akt, TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Regulation of Cell Size, Skeletal Muscle Fiber Development, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
Antigène
-